Raptor Investments, Inc. Changes Name to Snap N’ Sold Corporation While Shares Receive a Six-Month P

Lake Harmony, PA -- Raptor Investments, Inc. (Pink Sheets: RAPT), which has received an undervalued ‘Buy’ recommendation and price target of $.50 by Independent Research & Analytics of New York, New York, after the Company’s press release announced the intent to change its name to Snap n’ Sold Corporation.

For more information, go to www.vlcn.com/rapt62305.htm

TheNewsWire Gainers are Microtek Medical Holdings Inc (Nasdaq: MTMD), WSI Industries Inc (Nasdaq: WSCI), Dynavax Technologies Corp (Nasdaq: DVAX), Dennys Corp (Nasdaq: DENN), Nastech Pharmaceutical Company Inc (Nasdaq: NSTK), Oscient Pharmaceuticals Corp (Nasdaq: OSCI), OpenTV Corp (Nasdaq: OPTV) and Innovo Group Inc (Nasdaq: INNO).

TheNewsWire Decliners are Bioprogress PLC (Nasdaq: BPRG), Steel Technologies Inc (Nasdaq: STTX), Fuel-Tech NV (Nasdaq: FTEK), Millennium Cell Inc (Nasdaq: MCEL), ATI Technologies Inc (Nasdaq: ATYT), Evergreen Solar Inc (Nasdaq: ESLR), Myriad Genetics Inc (Nasdaq: MYGN) and Bed Bath & Beyond Inc (Nasdaq: BBBY).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $595.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact:
C.P. Barry
Company: http://www.OTCReport.com
Phone: 1.888.478.7669
Source: OTC Report

This press release was issued through GroupWeb EmailWire.Com. For more information on press release distribution, go to http://www.emailwire.com.